Introduction
Commonly available, effective, but at the same time increasingly more aggressive therapeutic methods are associated with an increase the number of patients hospitalized in pediatric intensive care units (PICU). Furthermore, the risk of AKI associated with those medical procedures and of nephrotoxic medications may be increased. This phenomenon resulted to an increased number of patients with AKI, however, the precise incidence rate of this complication has been reported only in approximate values [1] .
The majority of documented cases of AKI in pediatric patients described children who had already developed renal failure (stage F) and required renal replacement therapy (RRT) [2] [3] [4] [5] . Nevertheless, the results of recent studies indicate that a low increase in serum creatinine (SCr), amounting only to 10%-24%, was positively correlated with duration of hospitalization and cost of treatment and was an independent factor of morbidity and mortality risk both in adult patients and in children [6, 7] .
Material and Methods
The objective of the present study was a retrospective analysis of AKI in PICU patients, taking into consideration epidemiology and prevalence of diagnosing this complication depending on the definition employed. Furthermore, a number of diagnostic parameters were meticulously evaluated as potential predictors of mortality. Data from such studies might be crucial for the development of an diagnostictherapeutic algorithm for AKI pediatric patients allowing an early identification of high risk groups. The early diagnosis of AKI will lead to immediate therapeutic interventions before the development of loss of renal function (stage L) or end stage renal disease (stage E) [1, 8, 9] .
The study included 25 children (8 newborns, 8 infants, 9 older children) hospitalized in PICU of the University Children's Hospital of Cracow, Poland in the period between January 1st, 2006 and December 31st, 2012. The medical records of these patients featured the ICD10 N17 code (AKI). All children had bladder catheters and their hourly urine output (UO) was monitored.
In the present study, a change in the prevalence of AKI diagnosing depending on the employed definition of "zero point", which assessed the initial kidney function, was analyzed. In all patients, the diagnosis of AKI was established employing the pRIFLE scale criteria [10] , with the initial values of SCr or eGFR determined by the following methods:
The statistical description of the results and comparative analysis of their distribution were performed using respectively: the mean value, range, standard deviation, median value, first and third quartiles, t-Student test and -in view of the lack of certainty as to all the investigated groups meeting the assumptions of the t-Student test -the rank sum Wilcoxon test. In addition, the ROC curve analysis was performed, resulting in calculating the area under the curve and establishing the cut-off point, for which the following values were determined: the LR coefficient (at the same time constituting the odds ratio) as well as sensitivity and specificity. The survival analysis was performed using the Kaplan-Meier curves with the log-rank test, Cox-Mantel test and Gehan generalized Wilcoxon test. The significance of the difference between two-stage distributions was assessed by the one-sided Fisher's exact test. The calculations were performed using the Matlab package (MATLAB and Statistics Toolbox Release 2013a, The MathWorks, Inc., Natick, Massachusetts, USA) and verified by the STATISTICA package (V. 10, StatSoft, Inc., www.statsoft. com). The threshold value of p=0.05 was adopted while assessing statistical significance.
Results
The most common primary diagnoses established in the analyzed population of children with AKI were hemato-oncologic diseases; AKI with a nephrologic background was diagnosed in a single patient only. The most frequent coexisting diagnosis, secondary to the primary disease, was multiorgan failure (MOF). Nephrologic causes were noted in two cases only (i.e. autosomal recessive polycystic kidney disease as a primary diagnosis and one kidney necrosis accompanying necrotizing enterocolitis as coexisting diagnosis). Cardiac diseases were the most common primary causes of AKI in the group of newborns, while hemato-oncologic diseases predominated in the group of older children. Table 1 presents the primary and secondary diagnoses noted in the analyzed population.
The mean duration of hospitalization in PICU of the child with AKI was 35 days, with newborns being hospitalized for the longest period and the duration of hospitalization decreasing in the older age groups (Figure 1 ).
All the newborns and infants were on mechanical ventilatory support, while mechanical ventilation was required by 78% of the older children. The longest period of ventilatory support was required by the newborns, but in the analysis of the percentage of mechanical ventilation days vs. the entire hospitalization period in PICU, no significant differences were demonstrated between particular age groups. The majority of children required parenteral nutrition. Table 2 presents detailed clinical data of the children hospitalized in PICU.
Nephrotoxic aminoglycosides were employed in two children only, with the mean treatment duration of 7 days. Vancomycin was also rarely administered. Loop diuretics were used in all the children; no difference was noted in the percentage of duration of loop diuretics administration vs. the entire hospitalization in PICU for particular age groups. The longest time of using dopaminergic medications, adrenaline and noradrenaline was observed in the group of newborns; there was a tendency towards shortening the duration of administration of the above pharmaceuticals in older age groups. ACE inhibitor (enalapril) was used in 9 patients (36%), including 4 newborns (50%), which was the consequence of the highest prevalence of cardiac diseases as the cause of AKI in this age group. One-half newborns required cardiac surgery which took place from 9-th to 18-th day of PICU stay.
The mean minimum urine output in the investigated group of children was 0.82 ml/ kg/h, with the group of newborns demonstrating nonoliguric AKI (UO 1.19 ml/kg/h). The phenomenon of nonoliguric AKI in newborns was also confirmed by the analysis of the mean urine output in the first week of hospitalization, which in this age group equaled 2.65 ml/ kg/h (as compared to 1.4 ml/kg/h in the older children). The mean onset time of oliguria (defined as UO below 0.5 ml/kg/h/minimum 16 hours; pRIFLE stage I -injury) was on day 5 of hospitalization. The mean time of determining creatinine concentration in PICU patients was day 2 of hospitalization.
Stage F -failure -was noted in 84% of the investigated children, with the prevalence being 75% in newborns and infants and 100% in older children. The mean time of detect-employed method of determining the initial value of SCr or eGFR to be used in the pRIFLE scale in a given age group, the authors demonstrated that AKI could have been diagnosed in every case, regardless of the selected method of determining the "zero point". On the other hand, the criteria of the value of hourly urine output classified as oliguria (stage I according to pRIFLE; UO < 0.5 ml/kg/h/min.16 hours) -as the prerequisite of AKI diagnosis establishment -were met by 12 (48%) of the children (25% of newborns, 50% of infants and 66.7% of older children). The data confirmed the observation of nonoliguric AKI in the population of newborns and infants. Table 4 presents particular methods of diagnosing AKI in the group of the analyzed children. Renal replacement therapy (RRT) was required by one-half of the children; the mean RRT duration was 11.4 days (or 32.6% of the total hospitalization in PICU). The most frequently employed methods were peritoneal dialysis (50%) and continuous dialysis techniques (25%).
The mean duration of AKI in the investigated group of children was 12.2 days, what equaled 60% of the total hospitalization time in PICU. The longest duration of AKI was noted in the group of newborns (20 days), being equal to 50% of their hospitalization time in PICU. Table 3 presents a detailed characterization of kidney function in the analyzed population.
While analyzing the prevalence of establishing the diagnosis of AKI depending on the Table 2 . Clinical characterization of the pediatric study population In the investigated group, 40% of the children died. The percentage of AKI duration vs. the total hospitalization time in PICU was significantly higher in the group of children with a negative outcome (79.77% vs. 46.19 %; p<0.05). The deceased children were younger compared to the survivors, however this difference was not statistically significant.
Death, most commonly being a consequence of multiorgan failure (MOF; 6 cases of MOF in a group of 10 deceased children), usually secondary to hemato-oncologic diseases (5/10) occurred on day 19.4. The surviving children revealed the mean PICU hospitalization duration of 45.5 days, hence the resultant longer duration of RRT in this group of patients. These children predominantly suffered from cardiac diseases (7/15) .
With regard to the survival rate in MOF patients -death occurred in 6/14 (42,3%) patients with MOF and this incidence was higher (although not statistically significant than that of patients without MOF (4/11, 36%).
All the deceased children required mechanical ventilatory support, which was employed practically during their entire hospitalization in PICU and was significantly longer with respect to the percentage of ventilatory support vs. the total hospitalization time in PICU than in the group of surviving children (p=0.001). Total parenteral nutrition (TPN) was employed in all the deceased children (mean time: 8.8 days) and in 80% of the surviving children (mean time: 13.67 days). No differences were noted in the frequency and duration of using dopaminergic medications between the group of deceased children and the survivors. A difference was observed only in the frequency of adrenaline and noradrenaline usage; the medications were employed twice as frequently in the group of the deceased children.
Although the value of hourly UO is not a reliable marker when diagnosing AKI (especially in newborns and infants), nevertheless, its decreased value proved to be an indicator of a poor prognosis. In the group of the deceased children as compared to the surviving patients, not only was the mean minimum value of UO lower by half (0.52 vs. 1.00 ml/kg/h), but also the averaged UO values in the first and second week of hospitalization were lower (1.49 vs. 2.57 ml/kg/h and 1.77 vs. 2.76 ml/kg/h, respectively), with the difference of the minimum UO in the first week being statistically significant (p < 0.05). Figure 2 presents the Kaplan-Meier survival curves that document the cumulative survival ratio (CSR) of AKI patients in PICU depending on the criterion of oliguria presence (oliguria being defined as UO <0.5 ml/kg/h/min.16 hours). As it follows from the analysis, the final CSR (FCSR) of the patients who had not developed oliguria equaled 49%, while for children who had met the oliguria criterion, the respective value was only 37%, with the difference being borderline significant (p=0.08 in the log-rank and Cox-Mantel test; p=0.06 in the Gehan-Wilcoxon test). Figure 3 presents the ROC curve plotted for the number of deaths as depending on the mean value of hourly UO in the first week of hospitalization in PICU. As it follows from the analysis, in the selected cutoff point of the curve equaling 1.4 ml/kg/h, the likelihood ratio (LR) was 3.75 (at 50% sensitivity and 87% specificity). This means that the ratio of the deceased children to the surviving children following the application of the condition describing the UO value as < 1.4 ml/kg/h in comparison to the same ratio in the studied population increased 3.75 times.
As it has been already mentioned, the risk of death in the studied population was 40%, but the same risk in children, in whom the mean UO in the first week of hospitalization in PICU had not exceeded 1.4 ml/kg/h was 71% (PPV=0.71), and thus, the risk increased in the patients indicated by the test by a factor of 1.8.
The high prognostic value of UO was also supported by the fact that a difference was observed in the oliguria criterion as the prerequisite of diagnosing AKI (0.5 ml/kg/h/ min. 16 hours -stage I), the difference being seen in 70% of the subjects in the group of the deceased children and only in 33% of the surviving children.
However this difference was not reaching significance (p=0.08, Fisher's exact test), possibly due to the small number of patients. Table 5 presents a comparison of selected clinical parameters of the surviving children vs. the deceased patients. Fig. 3 . The ROC curve plotted for the number of deaths as depending on the mean urine output value in the first week of hospitalization in PICU for all AKI patients; AUROC: 75% for the selected cut-off value of 1.4 ml/kg/h, likelihood ratio (LR): 3.75; sensitivity: 50%; specificity: 87%. 
Discussion
The present study has included such factors as the prevalence, duration of hospitalization and mortality rates of patients with AKI, as well as AKI diagnosing based on the pRIFLE scale criteria depending on the employed initial value of SCr or eGFR.
According to various authors, the mean incidence of AKI (diagnosed based on the pRIFLE scale criteria) in PICUs falls within a very broad range, from 4.5% [16] to 82% [1] with the mean value being 49% (Table 6 ). In the seven year period of the study the diagnosis of AKI (code N17) was established only in 25 cases (1.24% of the total number of PICU patients at this period which amounted to 2014), which seems to be a surprisingly low. The presented prevalence rate illustrates a situation when the above diagnosis was established monthly only in 0.3 patients treated in PICU or when a single case of AKI was diagnosed every 3.36 months.
A significant cause of a low frequency of diagnosing AKI is the fact that over 4 years, PICU fulfilled the role of the postoperative unit, what caused an increase in the total number of patients. Nevertheless, the undoubtedly dedicated medical staff should be more sensitive to the problems and epidemiology of AKI in PICU. Such a low frequency of diagnosing this complication may result from the fact that over the seven years in question, renal replacement therapy was required by 12 children only. Moreover, physicians are still convinced of the importance of maintaining UO, the notion being grossly overemphasized. This has been demonstrated in the present study, where the majority of newborns and infants (10/16) already diagnosed with AKI still showed normal UO values. The value of hourly UO cannot be a reliable marker sufficient to diagnose AKI in the youngest children. Decreased UO starts to be of a diagnostics value only in children above 1 year of life which was noted in this study. A high importance of modified criteria in diagnosing AKI in the group of newborns was also found by Ricci et al. [17] and Bezerra et al. [18] , who maintain the position advocating using the neonatal RIFLE scale, where the criterion of normal UO has been established as 1.5 ml/ kg/h, and stages R and I begin respectively at UO < 1.5 ml/kg/h/24 hours and < 1.0 ml/ kg/h/24 hours.
The prevalence of establishing the diagnosis of AKI depending on the employed method of assessing the initial kidney function was analyzed in this study. In view of the very low number of patients in the studied population, it has not been possible to demonstrate differences in the prevalence of diagnosing AKI depending on the method of estimating the initial value of eGFR or SCr for the pRIFLE scale (Tab. 4). Irrespectively of the employed method, each diagnosed case met the criteria of AKI diagnosis. According to Zappitelli et al. [19] , various methods of estimating initial eGFR determine the frequency of diagnosing AKI, with the percentage values dispersed from 12% to 88%.
Nevertheless, even with such a limited clinical material in this study -the differences were found in the prevalence of diagnosing AKI based on the criterion of hourly urine output (UO < 0.5 ml/kg/h/min. 16 hours). The mean prevalence of diagnosing AKI based on the UO criterion for the total studied population of children was 48% (Tab. 3, Tab. 4).
The issue of differences in the prevalence of diagnosing AKI in children hospitalized in PICU depending on the employed definition of initial kidney function is widely analyzed in the literature on the subject [1, 20] . According to Akan-Arikan et al. [1] , who -in case the value of SCr from the period up to 3 months prior to admission to PICU had not been available -estimated the initial kidney function in 150 children based on the assumption that normal GFR equaled 100 ml/min/1.73 sq. m, the prevalence of AKI diagnosed based on the increase of SCr (in keeping with the pRIFLE scale) was 47.2%, while when estimations were based on urine output, the relevant value was only 17.9%. Similar results were obtained by Plötz et al., who adopted the same study conditions as Akan-Arikan et al. [1] in their population of 103 children. According to Plötz, the prevalence of AKI diagnosed based on an increase of SCr (pRIFLE) was 44.7%, while when based on urine output, the value was only 5.8% [20] .
The low "diagnostic vigilance" in diagnosing AKI in the analyzed population of children as compared to the data from the literature is also supported by the fact that in the present Table 6 . AKI incidence, duration of hospitalization and mortality rates of children with AKI in PICU based on the literature and data collected in the present study study, as many as 21 children (84%) were classified as stage F and only one child as the earliest risk stage (R) and three children as stage I (Tab. 3). Data from the literature addressing this issue are somewhat different.
Zapitelli et al. [21] analyzed a group of 140 children, whose initial kidney function -in case the value of SCr from the period up to 3 months prior to admission to PICU had not been available -was determined based on the assumption that normal GFR equaled 120 ml/ min/1.73 sq. m. In this study, the prevalence of AKI diagnosed based on a decrease in eGFR in keeping with the pRIFLE scale was 75.7%, with 35.7% being at the risk stage R, 22.1% at the injury stage I and only 17.9% at the failure stage F. Kavaz et al., who adopted the same study assumption, analyzed a group of 189 children, in whom AKI was seen in 35.9% of cases and demonstrated the following prevalence of particular pRIFLE stages: R -7%, I -18.5% and F -9.6% [22] . In the previously quoted study of Plötz et al., the investigators demonstrated that at the general AKI prevalence value of 58%, as many as 52% of children reached the risk stage, 37% -the injury stage, and only 11% -the failure stage [20] . According to Washburn et al. , in the population of 137 children, AKI was noted in 75.2% of patients; with the risk stage seen in as many as 36.5% of cases, the injury stage -in 20.4% and the failure stage -only in 18.3% of children [23] . In the reports of Bresolin et al. and Hui et al., in whom the initial kidney function in case the value of SCr from the period up to 3 months prior to admission to PICU had not been available was determined based on the assumption that normal GFR equaled 100 ml/min/1.73 sq. m, the analysis included 126 and 140 children, respectively. The prevalence of AKI and the prevalence of its particular stages in the above investigations was 46% (R -17.4%, I -16.7%, F -11.9%) and 56% (R -23%, I -20%, F -12%), respectively [24, 25] . In the majority of the above quoted reports (excluding the papers by Plötz et al. [20] ), the prevalence rates of particular pRIFLE stages referred to all the hospitalized children, nevertheless, a clear tendency towards stages R and I prevailing over stage F could be noted.
According to particular authors, the mean mortality rate in patients with AKI hospitalized in PICU ranges from 8.9% [26] to 55.4% [21] (mean: 28.5%), being from 1.3 to 12 (mean: 10.2) times higher as compared to the general mortality rate in such units. In the presently analyzed group, 40% of the children died, the value being 4.4 times higher as compared to the total mortality rate in PICU (in the analyzed period, mortality among the children without AKI was 9%; Tab. 6). Such a high mortality rate may result from the fact of assigning the N17 code (AKI) only to children with advanced disease, predominantly at the failure stage, therefore this study might not have included patients with earlier stages of AKI and this may explain the difference of the results in comparison with similar studies.
A similar conclusion arises following an analysis of the frequency of employing mechanical ventilatory support in children with AKI. In the analyzed group, mechanical ventilation was required by the mean percentage of 92% of the children, while according to various authors, the mean percentage of ventilatory supports in children with AKI ranged from 26.7% [26] to 63.8% [24] (mean: 46.3%), although there are reports confirming a 100% necessity of employing ventilators in the population of children with AKI [1] .
According to the literature, the mean duration of hospitalization in AKI patients in PICU ranges from 9 [27] to 51 days [26] (mean: 25.8 days). In the present study, the mean duration of hospitalization in PICU was 35 days, what is consistent with literature data on the length of hospitalization in PICU for AKI patients. In regard to patients without AKI according to particular authors -their mean PICU hospitalization time ranges from 2 [27] to 23.2 [24] (mean: 12) days, being from 0.86 [20] to 2.8 [26] (mean: 2,3) times shorter as compared to the PICU length of stay of patients with AKI. In the presently analyzed group, the PICU hospitalization duration of patients without AKI lasted 9.6 days being 3.6 times shorter comparing to PICU duration of hospitalization of AKI patients, which is statistically significant (p<0.05, Tab. 6).
Having performed our analysis exercising due diligence during the stage of material collection and statistical analysis of our results, we see the weak points of our study. We realize the study included a relatively small number of patients. In addition, it was retrospective and addressed a single PICU. However the unit is located in a multi-specialist hospital enjoying the status of a referral center, with a heavy patient load and a wide spectrum of patients at various ages and with diversified initial diagnoses. Nevertheless, we believe that a detailed analysis of retrospective data has allowed for characterizing the epidemiology, course and prognosis of AKI, providing a starting point for interventions aiming at improving the prognosis of children treated in PICU.
Conclusion
The analysis of the results allows for formulating the following conclusions: 1. Oliguria is not a reliable marker sufficient for diagnosing AKI in children below 1 year of life.
2. The risk of death in children, in whom the mean urine output in the first week of hospitalization in PICU did not exceed 1.4 ml/kg/h is almost two times higher as compared to the total population of hospitalized AKI children.
3. A retrospective analysis of the course of the disease and treatment employed in PICU confirm the fact that in many cases, acute kidney injury was diagnosed too infrequently and too late.
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